MRC1 and neoplasm: In the analysis of the myeloid compartment, there was a significant increase in the frequency of CD206+ macrophages, and no significant change in the frequency of CD206− macrophages in the tumor of mice treated with the triple combination therapy (Fig. S1, E and F), indicating a shift toward M2 macrophages.